Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7625494 | 0.90 | ALDH1A1 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL18333661 | 0.86 | ALDH1A1 (0.38) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL363117 | 0.85 | ALDH1A1 (0.37) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL5885009 | 0.85 | ALDH1A1 (0.37) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL9751967 | 0.83 | ALDH1A1 (0.36) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| Ammonia Solution, Strong SCHEMBL9221695 | 0.83 | ALDH1A1 (0.36) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL8680258 | 0.83 | ALDH1A1 (0.36) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL4613505 | 0.83 | ALDH1A1 (0.36) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL7218071 | 0.83 | ALDH1A1 (0.36) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL29253274 | 0.83 | ALDH1A1 (0.36) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 872 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066661-A1 | INVERTING PACKAGES, EMULSIONS, AND METHODS | STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED (GB) | 2025-02-27 | — | — | US | claimed |
| CN-117585963-A | Shrinkage-reducing anti-cracking type large-volume concrete and preparation method thereof | 中建商品混凝土有限公司 | 2024-02-23 | — | — | CN | claimed |
| US-11753580-B2 | Inverse emulsion compositions | KEMIRA OYJ (FI) | 2023-09-12 | — | — | US | claimed |
| US-11638950-B2 | Articles prepared using curable compositions based on polymerizable ionic species | ARKEMA FRANCE (FR) | 2023-05-02 | — | — | US | claimed |
| EP-3387025-B1 | INVERSE EMULSION COMPOSITIONS | KEMIRA OYJ (FI) | 2023-04-26 | — | — | EP | claimed |
| US-11597002-B2 | — | — | 2023-03-07 | — | — | US | claimed |
| CN-112423910-B | Articles prepared using curable compositions based on polymerizable ionic species | 阿科玛法国公司 | 2022-09-13 | — | — | CN | claimed |
| EP-3823772-B1 | ARTICLES PREPARED USING CURABLE COMPOSITIONS BASED ON POLYMERIZABLE IONIC SPECIES | ARKEMA FRANCE (FR) | 2022-08-03 | — | — | EP | claimed |
| CN-108947375-B | Hardening accelerator composition comprising a plasticizer | 建筑研究和技术有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-106749777-B | Water soluble hydrophobically associating copolymers | 巴斯夫欧洲公司 | 2021-10-26 | — | — | CN | claimed |
| US-6955803-B2 | Photoprotective compositions comprising sulfonic/hydrophobic amphiphilic polymers | L'OREAL (FR) | 2005-10-18 | — | — | US | claimed |
| US-20050086745-A1 | Oxidation dyeing composition for keratinous fibres on amphiphilic polymers of at least an ethylenically unsaturated monomer with sulphonic group and comprising a hydrophobic part | L'OREAL (FR) | 2005-04-28 | — | — | US | claimed |
| CN-1492753-A | Oxidizing composition for treating keratin materials, based on at least one ethylenically unsaturated monomer containing sulphonic groups and an amphiphilic polymer comprising hydrophobic portions | �ź㴫 | 2004-04-28 | — | — | CN | claimed |
| US-20040074015-A1 | Oxidising composition for treating keratinous materials based on amphiphilic polymers of at least an ethylenically unsaturated monomer containing a sulfonic group and comprising a hydrophobic part | L'OREAL (FR) | 2004-04-22 | — | — | US | claimed |
| US-20040071641-A1 | Photoprotective/cosmetic compositions comprising sulfonic/hydrophobic amphiphilic polymers | SOCIETE L'OREAL S.A. (FR) | 2004-04-15 | — | — | US | claimed |
| US-20040062728-A1 | Photoprotective compositions comprising sulfonic/hydrophobic amphiphilic polymers | SOCIETE L'OREAL, S.A. (FR) | 2004-04-01 | — | — | US | claimed |
| US-20030157047-A1 | Cosmetic composition for removing make-up from and clening the skin | L'OREAL (FR) | 2003-08-21 | — | — | US | claimed |
| US-20030108577-A1 | Cosmetic and/or dermatological acid composition containing an amphiphilic polymer | L'OREAL (FR) | 2003-06-12 | — | — | US | claimed |
| US-20030050201-A1 | Cleansing composition containing an amphiphilic polymer | L'OREAL (FR) | 2003-03-13 | — | — | US | claimed |
| US-20030036490-A1 | Stable composition with high electrolyte content containing an amphiphilic polymer | L'OREAL (FR) | 2003-02-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030157047-A1 | Cosmetic composition for removing make-up from and clening the skin | CUTA, DEGS1, LAGE3 | ALDH1A1 1947/4885CYP3A4 4736/4885CYP2C9 2887/4885 |
| US-20050086745-A1 | Oxidation dyeing composition for keratinous fibres on amphiphilic polymers of at least an ethylenically unsaturated monomer with sulphonic group and comprising a hydrophobic part | KRT18, ELOVL5, DSG1 | ALDH1A1 740/4885CYP3A4 1089/4885CYP2C9 501/4885 |
| US-20040062728-A1 | Photoprotective compositions comprising sulfonic/hydrophobic amphiphilic polymers | CUTA, PCNA, DSG1 | ALDH1A1 1614/4885CYP3A4 3640/4885CYP2C9 3018/4885 |
| US-20040071641-A1 | Photoprotective/cosmetic compositions comprising sulfonic/hydrophobic amphiphilic polymers | CUTA, DSG1, PCNA | ALDH1A1 2367/4885CYP3A4 4197/4885CYP2C9 3516/4885 |
| US-20030108577-A1 | Cosmetic and/or dermatological acid composition containing an amphiphilic polymer | KRT18, DSG1, CUTA | ALDH1A1 1813/4885CYP3A4 4791/4885CYP2C9 3975/4885 |
| US-20030036490-A1 | Stable composition with high electrolyte content containing an amphiphilic polymer | KRT18, DSG1, SCNN1A | ALDH1A1 3241/4885CYP3A4 4796/4885CYP2C9 4014/4885 |
| US-20040074015-A1 | Oxidising composition for treating keratinous materials based on amphiphilic polymers of at least an ethylenically unsaturated monomer containing a sulfonic group and comprising a hydrophobic part | KRT18, DSG1, CUTA | ALDH1A1 1273/4885CYP3A4 2145/4885CYP2C9 1276/4885 |
| US-20030050201-A1 | Cleansing composition containing an amphiphilic polymer | UGCG, SGMS1, SGMS2 | ALDH1A1 2273/4885CYP3A4 4012/4885CYP2C9 3469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.